HYPOGLYCAEMIC EPISODES EVALUATED BY CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH TYPE 2 DIABETES AND DIALYSIS-DEPENDENT END-STAGE RENAL DISEASE RANDOMISED TO 12-WEEK LIRAGLUTIDE OR PLACEBO TREATMENT

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

OriginalsprogEngelsk
ArtikelnummerSP426
TidsskriftNephrology Dialysis Transplantation
Vol/bind33
Udgave nummersuppl_1
Sider (fra-til)492-492
ISSN0931-0509
DOI
StatusUdgivet - maj 2018

ID: 199952451